Estimated Reading Time: 3 minutes
Hero MotoCorp, the world’s largest manufacturer of scooters and motorcycles,
reported its financial performance for the fourth quarter (January – March ‘21) of the
financial year 2021 (FY’21).
The Company’s Revenue from Operations for the quarter stood at Rs.8,686 Crore vs Rs.6238 Crore in Q4 FY’20 and Profit after Tax (PAT) at Rs.865 Crore vs Rs.621 Crore in Q4 FY’20. The EBITDA margin for the quarter stood at 13.9%. Consolidated Revenue and PAT stood at Rs.8,690 Crore and Rs.885 Crore respectively for the quarter.
The Company sold a total of 15.68 lakh units of two-wheelers during the Q4’21, registering a growth of 18.5% over the corresponding quarter in the previous year. The company had sold 13.23 lakh units in Q4’20. The company has been able to drive profitable growth through the combination of key strategic initiatives such as acceleration of Leap-II savings program to offset the higher commodity prices and input costs.
The company proposes a final dividend @ 1250% i.e. Rs. 25 per share and special dividend @ 500% i.e Rs 10 per share (face value of Rs. 2 per equity share). This dividend together with the Interim dividend, aggregates to Rs 90 per equity share and special dividend of Rs. 15 per equity share, taking the total dividend for the year 2020-21 to Rs 105 per share i.e 5250%.
The special dividend has been declared to mark the achievement of historic milestone of
achieving 100 Million cumulative production of two wheelers.
Mr. Niranjan Gupta, Chief Financial Officer (CFO), Hero MotoCorp, said, “The Covid-19
pandemic and resultant restrictions have been posing an unprecedented challenge for the
Indian economy and the auto industry. In 2020, as the restrictions were lifted, Hero MotoCorp managed to contain the effects of the pandemic on its business and financial performance. Thanks to strategic initiatives such as a strict discipline on expenses and prioritization of projects, we succeeded in substantially reducing general overhead costs and capex. Our tight working capital management has further helped in ensuring the much needed liquidity buffer in these times. Outstanding teamwork and timely measures helped us put the company on a stable course of recovery and eventual growth.
“As the coronavirus pandemic continues to pose a threat to lives and livelihood, our efforts in this quarter would be aimed at protecting people and their families. We expect normalcy to kick-in from the second quarter with a likely slowdown in Covid-19 cases and higher vaccination levels. Due to the evolving pandemic situation, we are remaining prepared to address any eventuality to be able to stabilize our business in the remaining months of the quarter.
“A healthy monsoon and harvest season and a rebound in GDP should aid the industry’s
recovery from Q2 onwards. The company also expects a significant growth in its global business with a renewed thrust on developing key-overseas markets.” In keeping with its commitment to the safety and welfare of its people and to break the chain of the spread of Coronavirus, Hero MotoCorp had proactively halted the plant operations temporarily in a staggered manner from April 22-May 1.
In view of the rapid escalation in the spread of Covid-19 across the country, the company
decided to extend the shutdown till May 9, 2021. The plant operations will resume on May 10. All corporate offices of the company are in Work from Home (WFH) mode and a very small number of colleagues are allowed in offices on rotation basis for the continuity of essential services.
The company had also initiated Covid-19 vaccination drive across the organization, including its permanent and contractual employees. Hero MotoCorp will bear the cost of
the vaccination drive for its workforce. The Company is also facilitating similar vaccination initiative across its group companies such as Hero FinCorp, Hero Future
Energies, Rockman Industries, Hero Electronix and AG Industries. In order to ensure the safety of people across its ecosystem, Hero MotoCorp is also working closely with its dealers and supply chain partners to facilitate similar vaccination for their employees.